4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0000899243-18-031952
Chief Scientific Officer sold 11,485 shares at $4.05 ($46,487)
- Chief Scientific Officer acquired 11,485 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ettenberg Seth Chief Scientific Officer | 2018-12-26 | Option exercise | +11,485 | $0.18 | $2,067 | 11,485 | D: show line 1 in the form |
| Ettenberg Seth Chief Scientific Officer | 2018-12-26 | Sale | −11,485 | $4.05 | $46,487 | 0 | D: show line 2 in the form |
| Open-market sales · 11,485 sh · avg $4.05 · $46,487 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ettenberg Seth Chief Scientific Officer | 2018-12-26 | Option exercise · Stock Option (Right to Buy) | −11,485 | 352,115 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…